Press Release
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
April 24, 2023
Read More at Our Investor SiteWe do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn and X for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Press Release
April 24, 2023
Read More at Our Investor SitePress Release
April 20, 2023
Read More at Our Investor SitePress Release
March 17, 2023
Read More at Our Investor Site